
# State of the Art

   - Review of previous studies identifying miRNAs associated with steatosis or similar metabolic diseases.
   - Comparison of findings regarding miRNAs in adipose tissue versus other relevant tissues (liver, blood, etc.).
   - Advances in the use of miRNAs as biomarkers for the diagnosis and prognosis of steatosis.
   - Bioinformatics tools and databases for predicting miRNA targets and analyzing their functional pathways.

---